Theratechnologies to Showcase Innovations at Top Investor Events
![Theratechnologies to Showcase Innovations at Top Investor Events](https://investorshangout.com/images/blog/ihnews-Theratechnologies%20to%20Showcase%20Innovations%20at%20Top%20Investor%20Events.jpg)
Theratechnologies to Showcase Innovations at Key Investor Conferences
Theratechnologies Inc., a leading biopharmaceutical company, is set to present at notable investor conferences. The Company’s President and CEO, Paul Lévesque, will lead discussions that highlight their innovative therapies aimed at addressing critical medical needs. The management team will also be available for personal discussions with investors during these significant events.
H.C. Wainwright Annual Global Investment Conference
One of the major conferences Theratechnologies will participate in is the H.C. Wainwright 26th Annual Global Investment Conference. This event is a fantastic opportunity for investors to learn more about the company's advancements and future plans.
Date and Presentation Details
The conference will take place from September 9-11. Theratechnologies has planned a virtual presentation on the morning of September 9, allowing attendees worldwide to engage with the Company’s insights.
Cantor Global Healthcare Conference
The 2024 Cantor Global Healthcare Conference is another key event where Theratechnologies will make its presence felt. Investors can gain firsthand insights from the Company regarding its recent initiatives.
Event Schedule
Scheduled for September 17-19, the Cantor conference offers a fireside chat with Paul Lévesque inside the Empire Ballroom 1 on September 18 from 8:00-8:30 a.m. ET. This intimate setting will focus on Theratechnologies' strategic overview and future growth plans, making it an important session for current and potential investors.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is dedicated to developing and commercializing innovative therapies that address unmet medical needs. The Company’s commitment to cutting-edge research and development is showcased through its progressive pipeline of treatments.
Commitment to Innovation
With a focus on enhancing the quality of life through groundbreaking therapies, Theratechnologies is determined to meet significant healthcare challenges. Their ongoing research efforts aim to provide solutions that empower patients and redefine treatment standards.
Connecting with Investors
The Company is keen to establish strong relationships with investors. Theratechnologies encourages interested parties to learn more about their initiatives through upcoming events and presentations.
Contact Information
For further inquiries, investors may reach out via email. Philippe Dubuc, the Senior Vice President and Chief Financial Officer, is available for investor-related questions at pdubuc@theratech.com. Media inquiries can be directed to Julie Schneiderman at communications@theratech.com. With a focus on transparency and communication, Theratechnologies ensures that stakeholders have access to relevant information.
Frequently Asked Questions
What is the main focus of Theratechnologies?
Theratechnologies is focused on developing innovative biopharmaceutical therapies that address unmet medical needs.
When will Theratechnologies present at the H.C. Wainwright Conference?
The virtual presentation will be held on the morning of September 9, 2024.
Where can I find more information about Theratechnologies?
Additional information about the company can be found on their official website and SEDAR+.
Who is the CEO of Theratechnologies?
Paul Lévesque is the President and CEO of Theratechnologies.
How can I reach the investor relations team?
Investors can contact Philippe Dubuc at pdubuc@theratech.com for inquiries related to investments.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Exploring the Future of Magnetoresistive RAM Technology Growth
- HII Launches REMUS 620 UUVs, Transforming Ocean Research Today
- Novo Nordisk's Strategic Share Repurchase Program Insights
- Exciting Merger of Dental Organizations Enhances Patient Care
- Revolutionizing Snack Time with Innovative Chip Packaging
- ISG's Innovative AI Contracting Solutions Revolutionize Compliance
- Forrester's Insights on AI Strategies for Tech Leadership in 2025
- Albemarle's Strategic Moves in the Options Market Explored
- Innovative Leadership in Hematology: Dr. Oscar Lahoud Joins
- Celebrating UKG's Commitment to Disability Inclusion Excellence
Recent Articles
- Watsco's Innovation in HVAC Industry and Upcoming Conference
- TGS Implements Employee Share Purchase Plan for Insiders
- Ryman Hospitality Offers Insight into Upcoming Conference Participation
- Progress Software's Upcoming Financial Results Announced
- Revolutionary Advances in IL-2 BiSKIT Research by Medicenna
- Alliance Trust PLC Reports Latest Net Asset Values for Shares
- Discovering Promising Financial Stocks for Investment Growth
- Surge in Trump Media Stocks: Impacts and Future Outlook
- Allied Gold Launches Trading on OTCQX Best Market Today
- SelectQuote Plans Earnings Release for Fiscal Year 2024 Insights
- Strategic Move: G Mining Ventures Completes Project Acquisition
- Simply Better Brands Corp. Expands TRUBAR™ Distribution Nationwide
- GR Silver Mining Plans $1.76 Million Private Placement Funding
- Methanex Acquires OCI's Methanol Business in Strategic $2.05B Deal
- Rethinking Strategies: How Creators Can Shine This Election
- Recognize Expands Portfolio with Blue Mantis Majority Investment
- First Citizens Bank Facilitates Major Financing for Swift Current
- Allied Gold Begins Trading on OTCQX Market for Growth
- Palatin Technologies Outlines Key Clinical Program Milestones
- 5 Accounting Software Tools Every Small Investor Needs to Know About
- G Mining Ventures Secures CentroGold Project for Future Growth
- Somite Therapeutics Partners with OmniaBio for Cell Therapy
- Viasat Plans Major Offering of Senior Secured Notes
- Discover the Revolutionary Protein Candy™: The Super Candy!
- Nvidia's Gross Margin Outlook: Strategic Moves Ahead
- Understanding Dividend Investing for Sustainable Wealth Growth
- The Impact of Wealth Taxes on High Net Worth Individuals
- Evolving Trends in the Laundry Detergent Market for 2034
- Exploring Insights from the Latest Half-Year Report 2024
- Vyne Dental Achieves Recognition in Digital Health Awards 2024
- Shifts in International Education Preferences Among Generations
- Squarespace and Permira Revise Merger Agreement for Enhanced Value
- Natural Grocers and Bitchin' Sauce Team Up for a Cause
- MercadoLibre's Ambitious Growth Plans in Latin America's Market
- Autonomix Sees Significant Pain Reduction in Clinical Trial
- Nova Vision Acquisition Corp. Expands Trust Account for Business Deal
- Aurora Cannabis and Vectura Launch Innovative Luo CBD Lozenge
- Quant Fund Market Expected to Grow to $38.90 Billion
- Maximizing Your Investment: Dividend Income from AT&T
- Zentalis Pharmaceuticals Unveils Promising Azenosertib Findings
- Coinbase Global: A Smart Growth Investment for Your Portfolio
- Financial Insights and Progress for 2024 from Australian Oilseeds
- Coppernico Metals Advances Drilling and Conference Engagements
- Market Recovery on the Horizon as Investors Anticipate Fed Moves
- Solaris Resources Advances Warintza Project with EIA Submission
- Major Drilling Reports Successful Annual Shareholder Meeting Results
- Apogee Therapeutics Welcomes Jeff S. Hartness as Chief CCO
- Akero Therapeutics Commences Patient Dosing in Key Study
- Tilray Medical's Breakthrough in Fibromyalgia Pain Relief
- Canoo's Exciting Relocation and Growth in Oklahoma and Texas